Sodium salicylate teratogenicity in vitro
- 1 October 1982
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 26 (2) , 167-171
- https://doi.org/10.1002/tera.1420260209
Abstract
Rat embryos were exposed to sodium salicylate in vitro at concentrations comparable to those used to produce terata in vivo. Embryos treated with 400, 600, or 800 μg Na salicylate/ml were compared with embryos treated with an equimolar concentration of NaCl. When compared to growth of the controls, a significant dose‐dependent decrease in growth parameters was observed. The incidence of abnormal embryos characterized by generalized swelling (particularly in the area of the rhombencephalon) was also dose dependent. This study demonstrates the teratogenicity of salicylate in the rat independent of maternal factors.This publication has 15 references indexed in Scilit:
- The in vitro teratogenicity of cyclophosphamide in rat embryosTeratology, 1982
- Metabolism of salicylate during chronic aspirin therapy.British Journal of Clinical Pharmacology, 1980
- Salicylate clearance, the resultant of protein binding and metabolismClinical Pharmacology & Therapeutics, 1979
- Pharmacokinetics of Salicylate in ManDrug Metabolism Reviews, 1979
- Salicylate Metabolism in TwinsJournal of Clinical Investigation, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Associations Between Oral Clefts and Drugs Taken During PregnancyInternational Journal of Epidemiology, 1975
- Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in manClinical Pharmacology & Therapeutics, 1972
- Studies on metabolism and identification of the causative agent in aspirin teratogenesis in ratsTeratology, 1971
- Salicylate Intoxication and Congenital AnomaliesArchives of environmental health, 1964